Prognostic significance of dobutamine stress echocardiography in patients with chronic kidney disease and known or suspected coronary artery disease: a 5-year follow-up study
Issued Date
2024-01-01
Resource Type
ISSN
09108327
eISSN
16152573
Scopus ID
2-s2.0-85204646653
Journal Title
Heart and Vessels
Rights Holder(s)
SCOPUS
Bibliographic Citation
Heart and Vessels (2024)
Suggested Citation
Leevongsakorn R., Kaolawanich Y., Karaketklang K., Ratanasit N. Prognostic significance of dobutamine stress echocardiography in patients with chronic kidney disease and known or suspected coronary artery disease: a 5-year follow-up study. Heart and Vessels (2024). doi:10.1007/s00380-024-02464-9 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/101394
Title
Prognostic significance of dobutamine stress echocardiography in patients with chronic kidney disease and known or suspected coronary artery disease: a 5-year follow-up study
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Dobutamine stress echocardiography (DSE) is an effective noninvasive modality for evaluating coronary artery disease (CAD), with high accuracy. However, data on the prognostic value of DSE in patients with chronic kidney disease (CKD) are limited. This study aims to assess the prognostic significance of DSE in patients with CKD and known or suspected CAD. We included consecutive patients with CKD stage 3 or higher and known or suspected CAD who underwent clinically indicated DSE between 2007 and 2017. The primary endpoint was all-cause mortality at 5 years. Univariable and multivariable analyses were conducted to identify predictors of all-cause mortality, with a p value < 0.05 considered statistically significant. A total of 274 patients were included in the study. The mean age was 64.0 ± 13.1 years, with 54% being male and 13.1% having known CAD. Among the patients, 64.6% had advanced CKD (≥ stage 4). Abnormal DSE was observed in 62 patients (22.6%). During a follow-up period of 7.0 ± 3.5 years, 78 patients (28.5%) died. The mortality rate was significantly higher in patients with abnormal DSE compared to those with normal DSE (48.4% vs. 22.6%, p < 0.001). Multivariable analysis identified age (hazard ratio [HR] 1.03, 95% confidence interval [CI] 1.008–1.05, p = 0.005), New York Heart Association (NYHA) functional class (HR 1.60, 95% CI 1.05–2.43, p = 0.03), and chronotropic index < 0.73 (HR 2.61, 95% CI 1.60–4.25, p < 0.001) as independent predictors of mortality. Conversely, a normal DSE result was found to be a protective factor (HR 0.49, 95% CI 0.30–0.81, p = 0.005). In conclusion, DSE demonstrated significant prognostic value in patients with CKD and known or suspected CAD. Age, NYHA functional class, and a chronotropic index < 0.73 were identified as independent predictors of all-cause mortality.